Table 1 Clinicopathological characteristics of AKI patients and healthy controls
AKI (n = 159) | Controls (n = 120) | |
|---|---|---|
Age (yr) | 45.09 ± 8.02 | 44.37 ± 7.64 |
Male/Female | 71/88 | 70/50 |
Creatinine (mg/dl) | 2.67 ± 1.02 | 0.73 ± 0.17 |
Apache II score | 20.3 ± 4.58 | NA |
AKI Stage | ||
Stage 1 (n,%) | 57 (35.8) | NA |
Stage 2 (n,%) | 64 (40.3) | NA |
Stage 3 (n,%) | 38 (23.9) | NA |
Mortality | 49 (30.8) | NA |
Cause of AKI | ||
Sepsis (n,%) | 89 (56.0) | NA |
Trauma (n,%) | 30 (18.9) | NA |
Cardiovascular (n,%) | 25 (15.7) | NA |
Other (n,%) | 15 (9.4) | NA |
RRT (n,%) | 60 (37.7) | NA |
RRT (days) | 10.6 ± 3.38 | NA |
RRT Dose | ||
25 ml/kg (n,%) | 35 (58.3) | NA |
35 ml/kg (n,%) | 25 (41.7) | NA |